Home > Healthcare > Medical Services > Assisted Reproductive Technology (ART) Market

Assisted Reproductive Technology (ART) Market Share

  • Report ID: GMI506
  • Published Date: Jan 2023
  • Report Format: PDF

Assisted Reproductive Technology Market Share

Some prominent companies operating in the assisted reproductive technology market are

  • LABORATOIRE CCD
  • Cooper Companies
  • Gynotec
  • Nidacon International AB
  • Vitrolife AB
  • Fertility Clinic Tokyo
  • Olympus Corporation
  • Hamilton Thorne
  • KITAZATO
  • SevenHills Hospital
  • Tambre Fertility Clinic Madrid

These firms generally engage in efficient strategies, including partnerships, acquisitions, and product portfolio expansions, with the aim to increase their business share.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for ART was worth more than USD 35 billion in 2022 and is set to record growth at over 6.5% CAGR between 2023 and 2032 owing to the high prevalence of infertility globally.

Procedure segment of the assisted reproductive technology (ART) market amassed over USD 33 billion in revenue in 2022 and is expected to progress steadily through 2032 driven by the growing adoption of in-vitro fertilization technology and IVF procedures owing to their high success rates.

North America assisted reproductive technology market valuation is expected to reach over USD 19.5 billion by 2032 due to the rising acceptance of fertility procedures, such as IVF and ART, among patients across the region.

Some of the major enterprises operating in the market are LABORATOIRE CCD, Cooper Companies, Gynotec, Nidacon International AB, Vitrolife AB, Fertility Clinic Tokyo, Olympus Corporation, Hamilton Thorne, KITAZATO, SevenHills Hospital, and Tambre Fertility Clinic Madrid, among others.

Assisted Reproductive Technology Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 17
  • Tables & Figures: 318
  • Countries covered: 15
  • Pages: 278
 Download Free Sample